News

September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual compression in patients undergoing transfemoral coronary angiography. The findings...

September 16, 2014 — A quarter of adults in the United States have two or more chronic medical conditions, as do more than two-thirds of seniors, yet there are few clinical practice guidelines for...

September 15, 2014 — A new gene-directed drug being tested through a research study called GENETIC-AF may improve care, quality of life and survival in patients with heart failure and atrial...

September 12, 2014 — Ecolab Healthcare announced the availability of the PD220 patient drape, the first to market specifically for Boston Scientific’s subcutaneous implantable cardioverter-...

September 12, 2014 — Volcano Corp. announced it will be launching its interventional precision guidance tools at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific...

September 11, 2014 — Patients who rely on pacemakers and defibrillators to maintain a normal heart rhythm run the risk of serious health complications if they don’t fully understand how the...

Medtronic AdaptResponse Global Clinical Trial Cardiac Resynchronization Therapy

Medtronic Inc. announced the first implants in a clinical trial that will compare patient and healthcare system outcomes — including patient mortality and hospitalizations — in ...

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according...

CorMatrix, CanGaroo, ECM Envelope

CorMatrix Cardiovascular announced that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix CanGaroo ECM Envelope for use with...

September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein isolation ablation in patients with AF and hypertension, according to research...

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced results from the X-VeRT trial, demonstrating once-daily rivaroxaban may be an alternative...

topera, catheter, FIRMmap

John Muir Health's Concord medical center is the first hospital in Northern California and one of just 20 hospitals in the nation to begin treating patients who suffer from atrial fibrillation (...

August 28, 2014 — Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P, for indicated patients with...

August 27, 2014 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its precision planning application for transcatheter...

Hemostasis Biolife StatSeal Advanced Disc Cath Lab

Cath Labs, interventional radiology suites and hospitals are continually trying to improve patient comfort as well as save time and reduce costs. With these goals in mind, Biolife introduces...

FDA Fysicon DataLinQ Pacemaker Programmer Acquisition Device

Fysicon received approval from the U.S. Food and Drug Administration (FDA) to market Fysicon DataLinQ. The Fysicon DataLinQ products enable complete automation.

August 22, 2014 — AliveCor announced the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AF), the most common form of...

Biotronik announced the first implantations worldwide of its new ICD and CRT-D series (implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators).

Cardiva Medical Inc. Vascade Vascular Closure System Series 3 financing U.S.

Cardiva Medical Inc. said it closed the first two tranches of a $16.5 million Series 3 private equity financing and a $12.5 million senior secured facility with GE Capital. The company will use...

A clinical trial being conducted at Mission Health on a special catheter could one day help people with a persistent heart condition that does not respond to medication.